ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company's products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient's knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient's knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: CFMS
- Previous Close: $5.18
- 50 Day Moving Average: $7.92
- 200 Day Moving Average: $8.54
- 52-Week Range: $4.80 - $13.83
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.77
- P/E Growth: -4.40
- Market Cap: $233.92M
- Outstanding Shares: 43,399,000
- Beta: 2.86
- Net Margins: -73.53%
- Return on Equity: -46.41%
- Return on Assets: -40.83%
Companies Related to ConforMIS:
- Current Ratio: 9.03%
- Quick Ratio: 7.98%
What is ConforMIS's stock symbol?
ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."
Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?
7 brokerages have issued 1-year price targets for ConforMIS's stock. Their predictions range from $7.00 to $14.00. On average, they expect ConforMIS's stock price to reach $10.75 in the next year.
When will ConforMIS announce their earnings?
ConforMIS is scheduled to release their next quarterly earnings announcement on Wednesday, May, 10th 2017.
Who owns ConforMIS stock?
ConforMIS's stock is owned by many different of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (2.29%), State Street Corp (1.38%), Frontier Capital Management Co. LLC (0.86%), Employees Retirement System of Texas (0.29%), Keybank National Association OH (0.11%) and ARK Investment Management LLC (0.10%). Company insiders that own ConforMIS stock include Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III.
Who sold ConforMIS stock? Who is selling ConforMIS stock?
ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Employees Retirement System of Texas, Frontier Capital Management Co. LLC and Metropolitan Life Insurance Co. NY. Company insiders that have sold ConforMIS stock in the last year include Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner and Philipp Lang.
Who bought ConforMIS stock? Who is buying ConforMIS stock?
ConforMIS's stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, ARK Investment Management LLC, Russell Investments Group Ltd., A.R.T. Advisors LLC, Trent Capital Management Inc. NC and Numeric Investors LLC.
How do I buy ConforMIS stock?
Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of ConforMIS stock cost?
One share of ConforMIS stock can currently be purchased for approximately $5.39.